Sysmex Full Year 2025 Earnings: EPS Misses Expectations

Simply Wall St · 05/17/2025 00:11

Sysmex (TSE:6869) Full Year 2025 Results

Key Financial Results

  • Revenue: JP¥508.6b (up 10% from FY 2024).
  • Net income: JP¥53.7b (up 8.1% from FY 2024).
  • Profit margin: 11% (in line with FY 2024).
  • EPS: JP¥86.07 (up from JP¥79.27 in FY 2024).
revenue-and-expenses-breakdown
TSE:6869 Revenue and Expenses Breakdown May 17th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Sysmex EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 7.3%.

The primary driver behind last 12 months revenue was the Japan segment contributing a total revenue of JP¥255.3b (50% of total revenue). The largest operating expense was General & Administrative costs, amounting to JP¥150.8b (69% of total expenses). Explore how 6869's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 7.1% p.a. on average during the next 3 years, compared to a 5.8% growth forecast for the Medical Equipment industry in Japan.

Performance of the Japanese Medical Equipment industry.

The company's shares are down 7.3% from a week ago.

Balance Sheet Analysis

While earnings are important, another area to consider is the balance sheet. We've done some analysis and you can see our take on Sysmex's balance sheet.